Early 2009 was a difficult time for the Fort Worth, Texas-based Ybarra family. Hope Ybarra, a mother of three, had been ...
An inhalable medicine with the potential to improve lung disease in people with cystic fibrosis, irrespective of their ...
From life-altering genetic conditions to promising new treatments, here's what you need to know about 7 inherited diseases ...
Did you see this? Nearly 1 in 10 Americans have asthma. Here's what causes it.
An Indianapolis family, after successfully navigating their second-born's battle with Cystic Fibrosis, is determined to help other expecting families learn about a newer therapy option.
Boehringer Ingelheim, IP Group, UK Respiratory Gene Therapy Consortium, and OXB launched the first-in-human clinical trial, known as LENTICLAIR 1.
NARBERTH, Pennsylvania (WPVI) -- "Take A Breather Foundation" based in Narberth is a stress relief outlet for people with cystic fibrosis. Their focus is to provide a "breather" to their recipients, ...
Medical Xpress on MSN13d
Early immune system changes contribute to lung damage in cystic fibrosisDespite new medication, cystic fibrosis often leads to permanent lung damage. Working with an international team, researchers from the Technical University of Munich (TUM) have discovered that the ...
Once-daily vanzacaftor-tezacaftor-deutivacaftor was safe and well-tolerated in children with cystic fibrosis, while ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback